Development of a sustained release dosage form for alpha-lipoic acid. I. Design and in vitro evaluation.
about
Advances in oral controlled drug delivery: the role of drug-polymer and interpolymer non-covalent interactions.Development of alpha-lipoic acid encapsulated chitosan monodispersed particles using an electrospray system: synthesis, characterisations and anti-inflammatory evaluations.Development of a sustained release dosage form for alpha-lipoic acid. II. Evaluation in human volunteers.Chitosan and sodium sulfate as excipients in the preparation of prolonged release theophylline tablets.
P2860
Development of a sustained release dosage form for alpha-lipoic acid. I. Design and in vitro evaluation.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Development of a sustained rel ...... esign and in vitro evaluation.
@en
Development of a sustained rel ...... esign and in vitro evaluation.
@nl
type
label
Development of a sustained rel ...... esign and in vitro evaluation.
@en
Development of a sustained rel ...... esign and in vitro evaluation.
@nl
prefLabel
Development of a sustained rel ...... esign and in vitro evaluation.
@en
Development of a sustained rel ...... esign and in vitro evaluation.
@nl
P2093
P2860
P356
P1476
Development of a sustained rel ...... esign and in vitro evaluation.
@en
P2093
Andreas E Clausen
Hans Schuhbauer
Roland Hanel
P2860
P356
10.1081/DDC-120027508
P407
P577
2004-01-01T00:00:00Z